Market cap
$92 Mln
Revenue (TTM)
$134 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
Market cap ($ Mln) |
92 | 490 |
Revenue ($ Mln) |
134 | 627 |
Net Profit ($ Mln) |
-10.63 | 47.18 |
Net Margin (%) |
-7.95 | 7.53 |
RoE (%) |
-- | 31.00 |
Price to Earnings |
-- | 11.43 |
Price-To-Book |
0.42 | 3.04 |
Cashflow ($ Mln)
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
Cash From Operating Activities
|
5.81 | 35.90 |
|
Cash Flow from Investing Activities
|
-- | -8.86 |
|
Cash from Financing Activities
|
0.00 | -21.73 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
ROCE (%)
|
-19.62 | 14.58 |
|
ROE (%)
|
101.10 | 21.32 |
|
ROA (%)
|
-9.55 | 11.46 |
|
EBIT Margin (%)
|
-3.98 | -- |
|
Net Margin (%)
|
-7.95 | 6.62 |
|
Cash Profit Margin (%)
|
0.00 | -- |
Growth Ratios
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
Revenue Growth (%)
|
7.02 | -0.03 |
|
EBIT Growth (%)
|
85.28 | -- |
|
Net Profit Growth (%)
|
73.50 | 6.56 |
|
EPS Growth (%)
|
73.84 | 0.15 |
|
Book Value Growth (%)
|
-82.02 | -- |
Valuation Ratios
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
Price / Earnings
|
-10.43 | 8.48 |
|
Price / Book Value
|
-7.45 | 1.72 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
23.15 | 4.75 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
Debt to Equity
|
-2.92 | 0.40 |
|
Short term debt to equity ratio
|
-0.06 | 0.08 |
|
Current Ratio
|
1.57 | 2.53 |
|
Quick Ratio
|
1.57 | 2.43 |
|
Interest Coverage
|
-1.12 | 80.74 |
Operating Efficiency Ratios
| Gan (GAN) | IBEX (IBEX) | |
|---|---|---|
|
Debtors to sales (%)
|
3.09 | 21.16 |
|
Asset Turnover
|
1.20 | 1.73 |
|
Receivable days
|
24.97 | 71.82 |
|
Inventory Days
|
0.00 | 7.34 |
|
Payable days
|
56.85 | 18.14 |
|
Cash Conversion Cycle
|
-31.88 | 61.02 |